Androgens and stroke: Good, bad or indifferent?

Experimental Neurology

Volumn 259, Issue , 2014, Pages 10-15

  Quillinan, Nidia ^a   Deng, Guiying ^a   Grewal, Himmat ^a   Herson, Paco S ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac arrest; Cerebral ischemia; Male androgens; Stroke; Testosterone

Indexed keywords

ANDROGEN; ANTIANDROGEN; ESTROGEN; PROGESTERONE; TESTOSTERONE;

AGING; BRAIN INJURY; BRAIN ISCHEMIA; CASTRATION; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CHILDHOOD STROKE; DISEASE MODEL; DISEASE PREDISPOSITION; GENDER; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; ADULT; ANIMAL; CHILD; CONVALESCENCE; FEMALE; GENETICS; HEART ARREST; MALE; MALE ANDROGENS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

CARDIAC ARREST; CEREBRAL ISCHEMIA; MALE ANDROGENS; STROKE; TESTOSTERONE;

ADULT; ANDROGENS; ANIMALS; BRAIN ISCHEMIA; CHILD; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; RECOVERY OF FUNCTION; SEX CHARACTERISTICS; STROKE;

EID: 84907293629     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.02.004     Document Type: Review

References (82)

1. Ahlbom, E., Prins, G.S., Ceccatelli, S., Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 892 (2001), 255–262.
2. Angele, M.K., Schwacha, M.G., Ayala, A., Chaudry, I.H., Effect of gender and sex hormones on immune responses following shock. Shock 14 (2000), 81–90 (Augusta, Ga.).
3. Appelros, P., Stegmayr, B., Terént, A., Sex differences in stroke epidemiology: a systematic review. Stroke 40 (2009), 1082–1090.
4. Azoulay, L., Yin, H., Benayoun, S., Renoux, C., Boivin, J., Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur. Urol. 60 (2011), 1244–1250.
5. Bain, J., Testosterone and the aging male: to treat or not to treat?. Maturitas 66 (2010), 16–22.
6. Basaria, S., Coviello, A.D., Travison, T.G., Storer, T.W., Farwell, W.R., Jette, A.M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., Choong, K., Lakshman, K.M., Mazer, N.A., Miciek, R., Krasnoff, J., Elmi, A., Knapp, P.E., Brooks, B., Appleman, E., Aggarwal, S., Bhasin, G., Hede-Brierley, L., Bhatia, A., Collins, L., LeBrasseur, N., Fiore, L.D., Bhasin, S., Adverse events associated with testosterone administration. N. Engl. J. Med. 363 (2010), 109–122.
7. Bennett, N.C., Gardiner, R.A., Hooper, J.D., Johnson, D.W., Gobe, G.C., Molecular cell biology of androgen receptor signalling. Int. J. Biochem. Cell Biol. 42 (2010), 813–827.
8. Caruso, A., Di Gerevini, V.G., Castiglione, M., Marinelli, F., Tomassini, V., Pozzilli, C., Caricasole, A., Bruno, V., Caciagli, F., Moretti, A., Nicoletti, F., Melchiorri, D., Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. J. Neurochem. 88 (2004), 1179–1185.
9. Chamorro, A., Urra, X., Planas, A.M., Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38 (2007), 1097–1103.
10. Chen, Z.J., Ughrin, Y., Levine, J.M., Inhibition of axon growth by oligodendrocyte precursor cells. Mol. Cell. Neurosci. 20 (2002), 125–139.
11. Cheng, J., Alkayed, N.J., Hurn, P.D., Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J. Cereb. Blood Flow Metab. 27 (2007), 1553–1562.
12. Cheng, J., Hu, W., Toung, T.J., Zhang, Z., Parker, S.M., Roselli, C.E., Hurn, P.D., Age-dependent effects of testosterone in experimental stroke. J. Cereb Blood Flow Metab 29 (2009), 486–494.
13. Cheng, J., Uchida, M., Zhang, W., Grafe, M.R., Herson, P.S., Hurn, P.D., Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia. J. Cereb. Blood Flow Metab. 31 (2011), 339–350.
14. Chock, B., Lin, T., Li, C., Swislocki, A., Plasma testosterone is associated with Framingham risk score. Aging Male 15 (2012), 134–139.
15. Courant, F., Aksglaede, L., Antignac, J., Monteau, F., Sorensen, K., Andersson, A., Skakkebaek, N.E., Juul, A., Le Bizec, B., Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography–tandem mass spectrometry method. J. Clin. Endocrinol. Metab. 95 (2010), 82–92.
16. Dash, R.J., Sethi, B.K., Nalini, K., Singh, S., Circulating testosterone in pure motor stroke. Funct. Neurol. 6 (1991), 29–34.
17. Dirnagl, U., Klehmet, J., Braun, J.S., Harms, H., Meisel, C., Ziemssen, T., Prass, K., Meisel, A., Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38 (2007), 770–773.
18. Dziennis, S., Akiyoshi, K., Subramanian, S., Offner, H., Hurn, P.D., Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Brain Behav. Immun. 25 (2011), 685–695.
19. Fanaei, H., Sadeghipou, H.R., Karimian, S.M., Hassenzade, G., Flutamide enhances neuroprotective effects of testosterone during experimental cerebral ischemia in male rats. ISRN Neurol., 2013.
20. Fineschi, V., Riezzo, I., Centini, F., Silingardi, E., Licata, M., Beduschi, G., Karch, S.B., Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int. J. Legal Med. 121 (2007), 48–53.
21. Firtser, S., Juonala, M., Magnussen, C.G., Jula, A., Loo, B., Marniemi, J., Viikari, J.S., Toppari, J., Perheentupa, A., Hutri-Kähönen, N., Raitakari, O.T., Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24–45 years. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 222 (2012), 257–262.
22. Foradori, C.D., Werner, S.B., Sandau, U.S., Clapp, T.R., Handa, R.J., Activation of the androgen receptor alters the intracellular calcium response to glutamate in primary hippocampal neurons and modulates sarco/endoplasmic reticulum calcium ATPase 2 transcription. Neuroscience 149 (2007), 155–164.
23. Fullerton, H.J., Wu, Y.W., Zhao, S., Johnston, S.C., Risk of stroke in children: ethnic and gender disparities. Neurology 61 (2003), 189–194.
24. Gatson, J.W., Singh, M., Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148 (2007), 2458–2464.
25. Gatson, J.W., Kaur, P., Singh, M., Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147 (2006), 2028–2034.
26. Golomb, M.R., Fullerton, H.R., Nowak-Gottl, U., Deveber, G., International Pediatric Stroke Study Group, Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40 (2009), 52–57.
27. Golomb, M.R., deVeber, G.A., MacGregor, D.L., Domi, T., Whyte, H., Stephens, D., Dick, P.T., Independent walking after neonatal arterial ischemic stroke and sinovenous thrombosis. J. Child Neurol. 18 (2003), 530–536.
28. Haffner, S.M., Valdez, R.A., Mykkänen, L., Stern, M.P., Katz, M.S., Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metab. Clin. Exp. 43 (1994), 599–603.
29. Hall, E.D., Pazara, K.E., Linseman, K.L., Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11 (1991), 292–298.
30. Hawk, T., Zhang, Y.Q., Rajukumar, G., Day, A.L., Simpkins, J.W., Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Research 796 (1998), 296–298.
31. Herson, P., Koerner, I., Hurn, P., Sex, sex steroids, and brain injury. Semin. Reprod. Med. 27 (2009), 229–239.
32. Herson, P.S., Bombardier, C.G., Parker, S.M., Shimizu, T., Klawitter, J., Klawitter, J., Quillinan, N., Exo, J.L., Goldenberg, N.A., Traystman, R.J., Experimental pediatric arterial ischemic stroke model reveals sex-specific estrogen signaling. Stroke 44 (2013), 759–763.
33. Hill, C.A., Fitch, R.H., Sex differences in mechanisms and outcome of neonatal hypoxia–ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol. Res. Int., 2012, 2012, 867531.
34. Hill, C.A., Alexander, M.L., McCullough, L.D., Fitch, R.H., Inhibition of X-linked inhibitor of apoptosis with embelin differentially affects male versus female behavioral outcome following neonatal hypoxia–ischemia in rats. Dev. Neurosci. 33 (2011), 494–504.
35. Hill, C.A., Threlkeld, S.W., Fitch, R.H., Reprint of “Early testosterone modulated sex differences in behavioral outcome following neonatal hypoxia ischemia in rats”. Int. J. Dev. Neurosci. 29 (2011), 621–628.
36. Hollander, M., Koudstaal, P.J., Bots, M.L., Grobbee, D.E., Hofman, A., Breteler, M.M., Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam study. J. Neurol. Neurosurg. Psychiatry 74 (2003), 317–321.
37. Holmes, S., Abbassi, B., Su, C., Singh, M., Cunningham, R.L., Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells. Endocrinology, 1–12, 2013.
38. Jeppesen, L.L., Jørgensen, H.S., Nakayama, H., Raaschou, H.O., Olsen, T.S., Winther, K., Decreased serum testosterone in men with acute ischemic stroke. Arterioscler. Thromb. Vasc. Biol. 16 (1996), 749–754.
39. Kaplan, S.A., Meehan, A.G., Shah, A., The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?. J. Urol. 176 (2006), 1524–1527.
40. Kapoor, D., Jones, T.H., Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?. Drugs Aging 25 (2008), 357–369.
41. Kupelian, V., Hayes, F.J., Link, C.L., Rosen, R., McKinlay, J.B., Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J. Clin. Endocrinol. Metab. 93 (2008), 3403–3410.
42. Lan, W.J., Priestley, M., Mayoral, S.R., Tian, L., Shamloo, M., Penn, A.A., Sex-specific cognitive deficits and regional brain volume loss in mice exposed to chronic, sublethal hypoxia. Pediatr. Res. 70 (2011), 15–20.
43. Lebesgue, D., Chevaleyre, V., Zukin, R.S., Etgen, A.M., Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 74 (2009), 555–561.
44. Littleton-Kearney, M., Hurn, P.D., Testosterone as a modulator of vascular behavior. Biol. Res. Nurs. 5 (2004), 276–285.
45. Liu, F., Yuan, R., Benashski, S.E., McCullough, L.D., Changes in experimental stroke outcome across the life span. J. Cereb. Blood Flow Metab. 29 (2009), 792–802.
46. Liu, M., Kelley, M.H., Herson, P.S., Hurn, P.D., Neuroprotection of sex steroids. Minerva Endocrinol. 35 (2010), 127–143.
47. Lo, W., Stephens, J., Fernandez, S., Pediatric stroke in the United States and the impact of risk factors. J. Child Neurol. 24 (2009), 194–203.
48. Manwani, B., Liu, F., Scranton, V., Hammond, M.D., Sansing, L.H., McCullough, L.D., Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp. Neurol. 249 (2013), 120–131.
49. Mayoral, S.R., Omar, G., Penn, A.A., Sex differences in a hypoxia model of preterm brain damage. Pediatr. Res. 66 (2009), 248–253.
50. McCullough, L.D., Hurn, P.D., Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol. Metab. 14 (2003), 228–235.
51. McIntyre, M.H., The use of digit ratios as markers for perinatal androgen action. Reprod. Biol. Endocrinol., 4, 2006, 10.
52. Meisel, C., Schwab, J.M., Prass, K., Meisel, A., Dirnagl, U., Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6 (2005), 775–786.
53. Moon, L.D., Brecknell, J.E., Franklin, R.J., Dunnett, S.B., Fawcett, J.W., Robust regeneration of CNS axons through a track depleted of CNS glia. Exp. Neurol. 161 (2000), 49–66.
54. Muller, M., van den Beld, A.W., Bots, M.L., Grobbee, D.E., Lamberts, S.W., van der Schouw, Y.T., Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109 (2004), 2074–2079.
55. Nakano, T., Hurn, P.D., Herson, P.S., Traystman, R.J., Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse. Brain Res. 1357 (2010), 124–130.
56. Nguyen, T.V., Yao, M., Pike, C.J., Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J. Neurochem. 94 (2005), 1639–1651.
57. Nguyen, T.V., Yao, M., Pike, C.J., Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons. Brain Res. 1298 (2009), 1–12.
58. Nuñez, J.L., McCarthy, M.M., Androgens predispose males to GABAA-mediated excitotoxicity in the developing hippocampus. Exp. Neurol. 210 (2008), 699–708.
59. Offner, H., Vandenbark, A.A., Hurn, P.D., Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 158 (2009), 1098–1111.
60. Olsen, N.J., Kovacs, W.J., Gonadal steroids and immunity. Endocr. Rev. 17 (1996), 369–384.
61. Palaszynski, K.M., Loo, K.K., Ashouri, J.F., Liu, H., Voskuhl, R.R., Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146 (2004), 144–152.
62. Pan, Y., Zhang, H., Acharya, A.B., Patrick, P.H., Oliver, D., Morley, J.E., Effect of testosterone on functional recovery in a castrate male rat stroke model. Brain Res. 1043 (2005), 195–204.
63. petere, Lang, J.T., McCullough, L.D., Pathways to ischemic neuronal cell death: are sex differences relevant?. J. Transl. Med., 6, 2008, 33.
64. Pike, C.J., Nguyen, T.V., Ramsden, M., Yao, M., Murphy, M.P., Rosario, E.R., Androgen cell signaling pathways involved in neuroprotective actions. Horm. Behav. 53 (2008), 693–705.
65. Ramsden, N., Shin, T.M., Pike, C.J., Androgens modulate neuronal vulnerability to kainite lesion. Neuroscience 122 (2003), 573–578.
66. Reeves, M.J., Bushnell, C.D., Howard, G., Gargano, J.W., Duncan, P.W., Lynch, G., Khatiwoda, A., Lisabeth, L., Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 7 (2008), 915–926.
67. Roselli, C.E., Liu, M., Hurn, P.D., Brain aromatization: classic roles and new perspectives. Semin. Reprod. Med. 27 (2009), 207–217.
68. Rothwell, P.M., Coull, A.J., Silver, L.E., Fairhead, J.F., Giles, M.F., Lovelock, C.E., Redgrave, J.N., Bull, L.M., Welch, S.J., Cuthbertson, F.C., Binney, L.E., Gutnikov, S.A., Anslow, P., Banning, A.P., Mant, D., Mehta, Z., Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular study). Lancet 366 (2005), 1773–1783.
69. Sacco, R.L., Identifying patient populations at high risk for stroke. Neurology 51 (1998), S27–S30.
70. Shimizu, T., Macey, T., Quillinan, N., Klawitter, J., Perraud, A., Traystman, R., Herson, P., Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J. Cereb. Blood Flow Metab., 1–7, 2013.
71. Shores, M.M., Smith, N.L., Forsberg, C.W., Anawalt, B.D., Matsumoto, A.M., Testosterone treatment and mortality in men with low testosterone levels. J. Clin. Endocrinol. Metab. 97 (2012), 2050–2058.
72. Spitzer, M., Huang, G., Basaria, S., Travison, T.G., Bhasin, S., Risks and benefits of testosterone therapy in older men. Nat. Rev. Endocrinol. 9 (2013), 414–424.
73. Steinlin, M., Pfister, I., Pavlovic, J., Everts, R., Boltshauser, E., Mori, A.C., Mercati, D.G., Hänggeli, C., Keller, E., Luetschg, J., Marcoz, J., Ramelli, G., Perez, E.R., Schmitt-Mechelke, T., Weissert, M., The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics 36 (2005), 90–97.
74. Tan, A.M., Zhang, W., Levine, J.M., NG2: a component of the glial scar that inhibits axon growth. J. Anat. 207 (2005), 717–725.
75. Taylor, L.G., Canfield, S.E., L, du, X., Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 115 (2009), 2388–2399.
76. Uchida, M., Palmateer, J.M., Herson, P.S., DeVries, A.C., Cheng, J., Hurn, P.D., Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J. Cereb. Blood Flow Metab. 29 (2009), 1454–1462.
77. Vagnerova, K., Liu, K., Ardeshiri, A., Cheng, J., Murphy, S.J., Hurn, P.D., Herson, P.S., Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway—do androgens matter?. Neuroscience 166 (2010), 476–481.
78. Wang, Y., Rudd, A.G., Wolfe, C.D., Age and ethnic disparities in incidence of stroke over time: the South London Stroke register. Stroke, 1–10, 2013.
79. Yang, S., Perez, E., Cutright, J., Liu, R., He, Z., Day, A.L., Simpkins, J.W., Testosterone increases neurotoxicity of glutamate in vitro and ischemia–reperfusion injury in an animal model. J. Appl. Physiol. 92 (2002), 195–201 (Bethesda, Md.: 1985).
80. Yeap, B.B., Hyde, Z., Almeida, O.P., Norman, P.E., Chubb, S.A., Jamrozik, K., Flicker, L., Hankey, G.J., Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J. Clin. Endocrinol. Metab. 94 (2009), 2353–2359.
81. Youssef, M.Y., Alqallaf, A., Abdella, N., Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease. BMJ, 2011, 2011.
82. Zhang, W., Cheng, J., Vagnerova, K., Ivashkova, Y., Young, J., Cornea, A., Grafe, M.R., Murphy, S.J., Hurn, P.D., Brambrink, A.M., Effects of androgens on early post-ischemic neurogenesis in mice. Transl. Stroke Res., 2013 [Electronic publication ahead of print].